Bahl & Gaynor’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2M | Sell |
321,634
-23,369
| -7% | -$1.83M | 0.13% | 114 |
|
|
2025
Q1 | $25M | Buy |
345,003
+84,878
| +33% | +$6.14M | 0.13% | 111 |
|
|
2024
Q4 | $23.1M | Buy |
260,125
+149,622
| +135% | +$13.3M | 0.12% | 108 |
|
|
2024
Q3 | $9.35M | Buy |
110,503
+4,027
| +4% | +$341K | 0.05% | 145 |
|
|
2024
Q2 | $9.84M | Buy |
106,476
+1,623
| +2% | +$150K | 0.06% | 137 |
|
|
2024
Q1 | $11.8M | Buy |
104,853
+4,538
| +5% | +$512K | 0.07% | 124 |
|
|
2023
Q4 | $9.34M | Buy |
100,315
+49,013
| +96% | +$4.57M | 0.06% | 134 |
|
|
2023
Q3 | $4.71M | Sell |
51,302
-5,552
| -10% | -$509K | 0.03% | 159 |
|
|
2023
Q2 | $6.9M | Buy |
56,854
+344
| +0.6% | +$41.8K | 0.04% | 142 |
|
|
2023
Q1 | $5.53M | Buy |
56,510
+871
| +2% | +$85.3K | 0.03% | 154 |
|
|
2022
Q4 | $4.51M | Sell |
55,639
-623
| -1% | -$50.5K | 0.03% | 161 |
|
|
2022
Q3 | $4.28M | Sell |
56,262
-18,631
| -25% | -$1.42M | 0.03% | 159 |
|
|
2022
Q2 | $8.18M | Sell |
74,893
-5,978
| -7% | -$653K | 0.05% | 130 |
|
|
2022
Q1 | $8.04M | Sell |
80,871
-765
| -0.9% | -$76.1K | 0.06% | 127 |
|
|
2021
Q4 | $7.8M | Buy |
81,636
+18,016
| +28% | +$1.72M | 0.04% | 139 |
|
|
2021
Q3 | $7.04M | Buy |
63,620
+5,666
| +10% | +$627K | 0.04% | 137 |
|
|
2021
Q2 | $6.72M | Buy |
57,954
+6,691
| +13% | +$775K | 0.04% | 142 |
|
|
2021
Q1 | $5.34M | Buy |
51,263
+1,288
| +3% | +$134K | 0.03% | 157 |
|
|
2020
Q4 | $6.01M | Buy |
49,975
+2,028
| +4% | +$244K | 0.04% | 136 |
|
|
2020
Q3 | $4.17M | Sell |
47,947
-1,069
| -2% | -$92.9K | 0.03% | 158 |
|
|
2020
Q2 | $3.97M | Sell |
49,016
-38,544
| -44% | -$3.12M | 0.03% | 155 |
|
|
2020
Q1 | $6.04M | Buy |
87,560
+55,095
| +170% | +$3.8M | 0.05% | 118 |
|
|
2019
Q4 | $3.71M | Buy |
32,465
+164
| +0.5% | +$18.8K | 0.03% | 173 |
|
|
2019
Q3 | $4.22M | Buy |
32,301
+3,576
| +12% | +$467K | 0.03% | 158 |
|
|
2019
Q2 | $3.52M | Buy |
28,725
+557
| +2% | +$68.3K | 0.03% | 174 |
|
|
2019
Q1 | $2.96M | Buy |
28,168
+805
| +3% | +$84.5K | 0.03% | 180 |
|
|
2018
Q4 | $2.8M | Sell |
27,363
-2,062
| -7% | -$211K | 0.03% | 163 |
|
|
2018
Q3 | $3.49M | Buy |
29,425
+656
| +2% | +$77.8K | 0.04% | 155 |
|
|
2018
Q2 | $2.76M | Buy |
28,769
+484
| +2% | +$46.5K | 0.03% | 181 |
|
|
2018
Q1 | $2.3M | Buy |
28,285
+950
| +3% | +$77.2K | 0.03% | 196 |
|
|
2017
Q4 | $1.97M | Buy |
27,335
+700
| +3% | +$50.6K | 0.02% | 219 |
|
|
2017
Q3 | $1.64M | Buy |
26,635
+4,300
| +19% | +$264K | 0.02% | 221 |
|
|
2017
Q2 | $1.35M | Buy |
22,335
+4,235
| +23% | +$256K | 0.02% | 229 |
|
|
2017
Q1 | $1.18M | Buy |
18,100
+6,885
| +61% | +$450K | 0.01% | 234 |
|
|
2016
Q4 | $788K | Buy |
+11,215
| New | +$788K | 0.01% | 265 |
|